AI assistant
Sending…
Imunon, Inc. — Director's Dealing 2017
Feb 22, 2017
35124_dirs_2017-02-22_17cd2fe1-d9e7-43cd-a45e-b92f3087e841.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2017-02-21
Reporting Person: Martinez Alberto R Jr (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-02-21 | Celsion Corporation Common Stock | P | 35000 | $0.23 | Acquired | 180081 | Direct |
Footnotes
F1: The Director purchased the shares on the open market
More from Imunon, Inc.
Capital/Financing Update
2026
Jun 4
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Annual Report
2026
May 4
Regulatory Filings
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Capital/Financing Update
2026
Mar 23
Regulatory Filings
2026
Mar 23